Effectiveness and cost effectiveness of self-monitoring and treatment of blood pressure in secondary prevention following stroke or transient ischaemic attack

Trial of the effectiveness and cost effectiveness of selfmonitoring and treatment of blood pressure in secondary prevention following stroke or transient ischaemic attack

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN86192648

Enrollment

156

Registered

2015-06-10

Start date

2012-11-01

Completion date

Unknown

Last updated

2020-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Stroke

Interventions

1. Self monitoring of Blood Pressure (SBPM) with supervised patient lead treatment changes 2. SBPM only with GP lead treatment changes 3. Standard GP lead control and

Study Entry : Single Randomisation only

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Age >= 55 years 2. Patients with TIA or stroke of mild/moderate severity (NIHSS =<15) 3. Patients that require BP management 4. Patients able and willing to undertake self BP measurement and guided alterations in therapy

Exclusion criteria

Exclusion criteria: 1. Patients with terminal illness with life expectancy less than six months including end staged condition e.g. end stage COPD Dementia 2. Patients with moderate to severe cognitive impairment 3. Patients not receiving or expected to start antihypertensive therapy

Design outcomes

Primary

Measure	Time frame
Ambulatory BP levels and control at 6 months; Timepoint(s): ABPM at 6 months after randomisation	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026